Micronized Palmitoylethanolamide-Polydatin Reduces the Painful Symptomatology in Patients with Interstitial Cystitis/Bladder Pain Syndrome.

Conclusions: These data highlight the potential benefit of m-PEA-Pol in patients with rare pathology such as IC/BPS and confirm the good safety profile of micronized PEA-based products. PMID: 31828153 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31828153?dopt=Abstract

Source: Biomed Res - December 14, 2019 Category: Research Authors: Cervigni M, Nasta L, Schievano C, Lampropoulou N, Ostardo E Tags: Biomed Res Int Source Type: research